ArticleClinical cancer research : an official journal of the American Association for Cancer Research2015

Low expression of the E3 ubiquitin ligase CBL confers chemoresistance in human pancreatic cancer and is targeted by epidermal growth factor receptor inhibition.

Brian E Kadera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.